抗足细胞抗体与特发性膜性肾病发病机制研究进展
被引量:1
摘要
特发性膜性肾病(idiopathic membranous nephropathy,IMN)是成人肾病综合征最常见的病理类型,约占我国原发性肾病综合征的25%-30%。国内北京、南京及上海的资料统计,膜性肾病发病率约占原发性肾小球疾病的9.9%-13.5%。
出处
《中国医师杂志》
CAS
2012年第10期1431-1433,共3页
Journal of Chinese Physician
参考文献32
-
1陆再英,钟南山.内科学.7版.北京:人民卫生出版社,2008,1:267-294.
-
2丁小强,刘春凤.特发性膜性肾病研究进展[J].中国实用内科杂志,2011,31(2):108-112. 被引量:59
-
3Glassock RJ. Diagnosis and natural course of membranous ne- phropathy. Semin Nephrol,2003,23 (4) :324-332.
-
4Glassock RJ. Human idiopathic membranous nephropathy-a mys- tery solved? N Engl J Med,2009,361(1) :81-83.
-
5Glassock ILl. The pathogenesis of idiopathic membranous nephrop-athy: a 50-year odyssey. Am J Kidney Dis,2010,56 ( 1 ) : 157- 167.
-
6HeymannW, Hackel DB, Harwood S, et al. Production of ne- phrotic syndrome in rats by Freund adjuvants and rat kidney sus- pensions. Proc Soc Exp Biol Med, 1959,100 (4) :660-664.
-
7Couser WG, Steinmuller DR, Stilmant MM, et al. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin In- vest, 1978,62 (6) : 1275-1287.
-
8Van Damme B J, Fleuren GJ, Bakker WW, et al. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest, 1978,38(4) :502-510.
-
9Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int, 1980,17 ( 1 ) : 1-13.
-
10Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A, 1982,79 (18):5557- 5561.
二级参考文献49
-
1Wasserstein AG. Membranous glomerulonephritis. J Am Soc N ephrol, 1997,8:664 - 674.
-
2Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol,2003 ,23 :324 - 332.
-
3Kuroki A, Shibata T, Honda H, et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med, 2002,41:936 - 942.
-
4Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to antl-neutral endopeptidase antibodies. N Engl J Med,2002,346:2053 -2060.
-
5Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic: membranous enephropathy. N Engl J Med,2009,361 : 11 - 21.
-
6Heymann W, Hackel DB, Harwood S, et al. Production of nephritic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med, 1959,100:660 - 664.
-
7Couser WG, Steinmuller DR, Stihnant MM, et al. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest, 1978,62 : 1275 - 1287.
-
8Van Damme B J, Fleuren GJ, Bakker WW, et al. Experimental glomer- ulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest, 1978,38:502 -510.
-
9Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glyeoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A, 1982,79:5557 -5561.
-
10Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med, 1983,157:667 - 686.
共引文献340
-
1陈宏,远方.基于真实世界回顾性分析特发性膜性肾病中西医临床研究[J].亚太传统医药,2020(12):162-165. 被引量:1
-
2胡青.低密度脂蛋白与高密度脂蛋白水平之比与冠心病的关系[J].中国医师杂志,2009,11(3):404-405. 被引量:1
-
3陈根荣,薛彦萍,张梅红.六分钟步行试验在慢性支气管炎需做肺功能筛选中的价值[J].中国医师进修杂志(内科版),2009,32(12):15-17. 被引量:1
-
4孙金明,田维,任益江,王开成.淡水近乎淹溺后并发急性肺水肿中机械通气的应用[J].中国医师进修杂志(内科版),2009,32(12):39-40.
-
5张军,钱贵宾,王鹏,曲敬,张育成.人工全髋关节置换术治疗系统性红斑狼疮继发股骨头缺血性坏死五例[J].中国修复重建外科杂志,2010,24(4):503-504.
-
6骆定海,吴建胜,贾国葆,黄智铭,陈民新.自身免疫性肝炎合并肝纤维化指标异常对疾病预后判断意义[J].医学研究杂志,2010,39(5):97-100. 被引量:3
-
7施伎蝉,蒋贤高,朱海燕,宁洪叶.甲型H1N1流行性感冒患者早期血常规及C反应蛋白特点分析[J].中华传染病杂志,2010(5):301-303. 被引量:4
-
8高世明,杨翠展,贾宏伟,于晓燕,王志萍,王敏霞,张艳春,杜刚,安学芬.阜康市哈族和汉族高血压、血脂异常、糖尿病调查分析[J].中国心血管病研究,2010,8(6):430-431. 被引量:1
-
9韩萍,齐蓉.痰热清联合左氧氟沙星氯化钠注射液治疗社区获得性肺炎疗效观察[J].山西医药杂志(下半月),2010,39(6):553-554.
-
10郑淑娟.老年重症医院获得性肺炎45例临床分析[J].山西医药杂志(下半月),2010,39(6):556-558. 被引量:1
同被引文献12
-
1Myrvang H. Glomerular disease:rituximab promising for idio- pathic membranous nephropathy [J]. Nat Rev Nephro1,2012,8 (10) :556.
-
2Ponticelli C, Passerini P. Management of idiopathic membra- nous nephropathy [J]. Expert Opin Pharmacother, 2010, 11 (13) :2163-2175.
-
3Waldman M,Austin HA. Treatment of idiopathic membranous nephropathyE J]. J Am Soc Nephrol, 2012,23 ( 10 ) : 1617- 1630.
-
4Arabi Z. Membranous nephropathy:treatment outline and risk stratification [J]. Avicenna J Med,2012,2 ( 3 ) :60-64.
-
5Beck LH Jr,Bonegio RG,Lambeau G, et al. M-type phospho- lipase A2 receptor as target antigen in idiopathic membranous nephropathy [J]. N Engl J,2009,361 ( 1 ) : 11-21.
-
6Li XL, Yah TK, Li HF, et al. IgG4-related membranous ne- phropathy with high blood and low urine IgG4/IgG ratio: a case report and review of the literature [ J ]. Clin Rhumatol, 2014,33 ( 1 ) : 145-148.
-
7Chen M, Li H, Li XY, et al. Tacrolimus combined with corti- costeroids in treatment of nephrotic idiopathic membranous ne- phropathy:A multicenter randomized controlled trial[ J]. Am J Med Sci ,2010,339 ( 3 ) :233-238.
-
8Naumovic R, Jovanovic D, Pavlovic S, et al. Cyclosporine ver- sus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study [ J ]. Biomed Pharmacother,2011,65 ( 2 ) : 105-110.
-
9陈朝红,刘志红,洪亦眉,秦卫松,张明超,曾彩虹,黎磊石.雷公藤甲素干预C5b-9诱导足细胞损伤的体外研究[J].肾脏病与透析肾移植杂志,2009,18(4):310-317. 被引量:34
-
10冯少尊,张平,谢玲.来氟米特、雷公藤多苷联合小剂量激素治疗特发性膜性肾病临床观察[J].中国社区医师(医学专业),2011,13(17):52-52. 被引量:9
二级引证文献16
-
1相敏,鲁凌飞,李雨彦,卢建东,熊国良.雷公藤治疗成人特发性膜性肾病的疗效及减少蛋白尿的Meta分析[J].内蒙古中医药,2022,41(10):163-168.
-
2刘书真.小剂量他克莫司联合雷公藤多苷治疗特发性膜性肾病患者的临床效果观察[J].临床研究,2015,23(5):86-87. 被引量:1
-
3楼红玫.醋酸泼尼松不同方案治疗特发性膜性肾病的效果对照评价[J].中华全科医学,2015,13(6):921-923. 被引量:14
-
4罗志芳.中西医结合治疗特发性膜性肾病临床疗效研究[J].中西医结合心血管病电子杂志,2015,3(2):116-117. 被引量:4
-
5殷松江,盛梅笑.雷公藤多苷治疗特发性膜性肾病有效性及安全性的Meta分析[J].临床肾脏病杂志,2016,16(1):12-21. 被引量:10
-
6李琳琳.激素联合不同免疫抑制剂治疗特发性膜性肾病的临床比较[J].中国医药指南,2016,14(16):180-181. 被引量:7
-
7和兴彩,赵峰波,李俊伟,贾英辉,刘勇志,牛玉芹,王跃刚,刘盼,张文阁,吕海燕.自拟清血消白方辨证治疗膜性肾病综合征疗效观察[J].现代中西医结合杂志,2016,25(31):3453-3454. 被引量:4
-
8黄兰兰.环孢素联合糖皮质激素治疗特发性膜性肾病的远期疗效及安全性研究[J].河北医学,2017,23(7):1202-1206. 被引量:18
-
9张健,李冀军,宋岩.小剂量环孢素联合小剂量激素治疗膜性肾病的疗效观察[J].临床肾脏病杂志,2017,17(11):671-675. 被引量:8
-
10侯佳兴.用不同剂量的泼尼松联合环孢素治疗特发性膜性肾病的效果分析[J].当代医药论丛,2018,16(2):70-71. 被引量:1
-
1曲贞,刘刚.特发性膜性肾病发病机制的研究进展[J].临床肾脏病杂志,2012,12(1):7-8. 被引量:2
-
2李娟.糖皮质激素联合环磷酰胺治疗特发性膜性肾病的效果观察[J].中国医学前沿杂志(电子版),2015,7(7):96-98. 被引量:11
-
3杨娜,梁祎,李雅萍,张晶,刘可先.霉酚酸酯联合雷公藤多甙片治疗特发性膜性肾病的临床疗效分析[J].华南国防医学杂志,2015,29(9):676-678. 被引量:8
-
4孙燕,高妍婷,王晓明.环磷酰胺口服及冲击治疗特发性膜性肾病的疗效比较[J].临床肾脏病杂志,2015,0(10):626-628. 被引量:8
-
5傅秀兰,徐耀文,张文,陈晓农,陈楠.原发性膜性肾病四联疗法的疗效[J].上海第二医科大学学报,2002,22(2):164-166. 被引量:1
-
6秦林芳,张绿凤,宋纯东.雷公藤多甙片联合半量激素治疗原发性膜性肾病30例[J].中医临床研究,2015,7(20):10-12. 被引量:3
-
7蔡娟娟,顾开宏,郭玉,徐丹,段亚丽,翁昌亚,陆晨.不同年龄特发性膜性肾病患者临床与病理分析[J].临床肾脏病杂志,2015,0(10):594-598. 被引量:6
-
8张晓龙,张翠欣,李丹.特发性膜性肾病药物治疗新进展[J].临床合理用药杂志,2017,10(1):179-181. 被引量:4
-
9韩莉,邓跃毅,陈以平,刘睿,陈永乐,钟逸斐,张先闻.肾9方联合清热膜肾冲剂治疗多药无效特发性膜性肾病临床观察[J].中国中西医结合杂志,2011,31(11):1496-1501. 被引量:19
-
10戴厚永,刘必成.特发性膜性肾病诊治进展[J].临床荟萃,2011,26(2):167-170. 被引量:3